Fulgent Genetics, Inc. FLGT Laboratory Services — Allocated Share Based Compensation Expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AllocatedShareBasedCompensationExpense.
The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fulgent Genetics, Inc.'s laboratory services — allocated share based compensation expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Fulgent Genetics, Inc.'s laboratory services — allocated share based compensation expense?
- Fulgent Genetics, Inc. (FLGT) reported laboratory services — allocated share based compensation expense of $7.64M in Q1 2026.
- How has Fulgent Genetics, Inc.'s laboratory services — allocated share based compensation expense changed year-over-year?
- Fulgent Genetics, Inc.'s laboratory services — allocated share based compensation expense decreased by 10.5% year-over-year, from $8.53M to $7.64M.
- What is the long-term trend for Fulgent Genetics, Inc.'s laboratory services — allocated share based compensation expense?
- Over 3 years (2022 to 2025), Fulgent Genetics, Inc.'s laboratory services — allocated share based compensation expense has grown at a -1.1% compound annual growth rate (CAGR), from $32.64M to $31.57M.
- What does laboratory services — allocated share based compensation expense mean?
- This represents the portion of total share-based compensation costs attributed to employees working within the laboratory services segment. It is a non-cash expense that reflects the cost of equity-based incentives used to attract and retain talent in the laboratory operations.